Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for BAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 2.15B
March 31, 2026 2.017B
December 31, 2025 1.968B
September 30, 2025 1.726B
June 30, 2025 1.686B
March 31, 2025 2.294B
December 31, 2024 1.766B
September 30, 2024 1.42B
June 30, 2024 2.095B
March 31, 2024 3.026B
December 31, 2023 3.082B
September 30, 2023 5.792B
June 30, 2023 1.726B
March 31, 2023 1.677B
December 31, 2022 1.722B
September 30, 2022 1.604B
June 30, 2022 1.856B
March 31, 2022 2.299B
December 31, 2021 2.956B
September 30, 2021 3.261B
June 30, 2021 3.14B
March 31, 2021 3.186B
December 31, 2020 3.736B
September 30, 2020 4.359B
June 30, 2020 4.085B
Date Value
March 31, 2020 4.11B
December 31, 2019 3.335B
September 30, 2019 3.009B
June 30, 2019 2.925B
March 31, 2019 1.908B
December 31, 2018 1.838B
September 30, 2018 2.86B
June 30, 2018 2.857B
March 31, 2018 2.947B
December 31, 2017 3.394B
September 30, 2017 3.517B
June 30, 2017 3.817B
March 31, 2017 2.858B
December 31, 2016 2.801B
September 30, 2016 2.597B
June 30, 2016 2.63B
March 31, 2016 3.443B
December 31, 2015 7.361B
September 30, 2015 6.126B
June 30, 2015 6.68B
March 31, 2015 2.53B
December 31, 2014 2.925B
September 30, 2014 2.078B
June 30, 2014 1.866B
March 31, 2014 2.049B

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Becton, Dickinson & Co. 864.00M
DexCom, Inc. 1.947B
Boston Scientific Corp. 648.00M
West Pharmaceutical Services, Inc. 435.80M
Abbott Laboratories 5.603B